Cannabis Use and Psychosis in Adolescents

This presentation will investigate cannabis use among adolescents and the associated risk factors for developing psychotic symptoms or a psychotic illness during adolescence. We will explore the impact of high-potency THC, the common perception of these substances as ‘natural’ and harmless, as well as the dose-dependent relationship between THC use and the development of psychosis.

Objectives:

  1. Evaluate some data about current substance use among adolescents
  2. Recognize some of the processes that THC and CBD influence natural cannabinoid receptors in the body
  3. Explore one theory of how THC may create a predisposition to psychosis
  4. Examine how tobacco and cannabis industries are influencing adolescent behaviors
  5. Analyze some case examples of cannabis use and development of psychosis and psychotic illness
     

This session is accredited for a maximum of .5 AOA Category 1-A credits. Credits commensurate with participation in the session will be awarded.

MOA Grievance Policy: All grievances should be initially directed in writing to the MOA Executive Director by email to info@mainedo.org who will share them with the MOA's Program Committee. Grievances will receive a response within 30 days of receipt. If you do not receive a satisfactory response, you may notify the Council on Continuing Medical Education, AOA, 142 East Ontario St., Chicago, IL 60611.